Literature DB >> 6176380

The relationship between plasma levels of the factor VIII complex and platelet release products (beta-thromboglobulin and platelet factor 4) in children with the hemolytic-uremic syndrome.

A C Appiani, A Edefonti, A Bettinelli, M M Cossu, M L Paracchini, E Rossi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6176380

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN： 0301-0430            Impact factor:   0.975


× No keyword cloud information.
  12 in total

Review 1.  Glomerular fibrin deposition and removal.

Authors:  J M Bergstein
Journal:  Pediatr Nephrol       Date:  1990-01       Impact factor: 3.714

2.  Shiga toxin 2 and lipopolysaccharide induce human microvascular endothelial cells to release chemokines and factors that stimulate platelet function.

Authors:  Fadila Guessous; Marek Marcinkiewicz; Renata Polanowska-Grabowska; Sudawadee Kongkhum; Daniel Heatherly; Tom Obrig; Adrian R L Gear
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

Review 3.  Shiga toxin pathogenesis: kidney complications and renal failure.

Authors:  Tom G Obrig; Diana Karpman
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

4.  Abnormalities of factor VIII related protein multimers in the haemolytic uraemic syndrome.

Authors:  P E Rose; S M Enayat; R Sunderland; P E Short; C E Williams; F G Hill
Journal:  Arch Dis Child       Date:  1984-12       Impact factor: 3.791

Review 5.  Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction.

Authors:  Carla Zoja; Simona Buelli; Marina Morigi
Journal:  Pediatr Nephrol       Date:  2010-04-28       Impact factor: 3.714

Review 6.  Platelet Signaling and Disease: Targeted Therapy for Thrombosis and Other Related Diseases.

Authors:  Jennifer Yeung; Wenjie Li; Michael Holinstat
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

7.  Shiga toxin binds human platelets via globotriaosylceramide (Pk antigen) and a novel platelet glycosphingolipid.

Authors:  L L Cooling; K E Walker; T Gille; T A Koerner
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

8.  Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome.

Authors:  Anne-lie Ståhl; Majlis Svensson; Matthias Mörgelin; Catharina Svanborg; Phillip I Tarr; Jody C Mooney; Sandra L Watkins; Roger Johnson; Diana Karpman
Journal:  Blood       Date:  2006-03-02       Impact factor: 22.113

9.  Plasmapheresis as a therapeutic measure in hemolytic-uremic syndrome in children.

Authors:  A Gillor; M Bulla; B Roth; K Bussmann; K Schrör; A Tekook; E Gladtke
Journal:  Klin Wochenschr       Date:  1983-04-01

10.  Down-regulation of platelet surface CD47 expression in Escherichia coli O157:H7 infection-induced thrombocytopenia.

Authors:  Ya-Lan Guo; Dan-Qing Liu; Zhen Bian; Chen-Yu Zhang; Ke Zen
Journal:  PLoS One       Date:  2009-09-22       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.